Clinical trial
Efficacy & Safety of Prophylaxis With Bemiparin in Cancer Patients With a…
NCT00311896 · Clinica Universidad de Navarra, Universidad de Navarra, Other · Terminated
Key facts
| NCT number | NCT00311896 |
|---|---|
| Title | Efficacy & Safety of Prophylaxis With Bemiparin in Cancer Patients With a Central Venous Catheter (BECAT) |
| Official title | Multicentric, Randomized, Placebo Controlled and Double-blind Study to Evaluate the Efficacy and Safety of Antithrombotic Prophylaxis With Bemiparin (3,500 UI/Day) in Cancer Patients With a Central Venous Catheter (CVC)(BECAT) |
| Lead sponsor | Clinica Universidad de Navarra, Universidad de Navarra, Other |
| Collaborators | Laboratorio farmacéutico ROVI |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cancer, Thrombosis |
| Intervention type | Drug |
| Interventions | Bemiparin, Placebo |
| Enrollment | 402 |
| Start date | Jul 1, 2005 |
| Primary completion | Feb 1, 2009 |
| Completion | Dec 1, 2010 |
| First posted | Apr 6, 2006 |
| Last update posted | Jun 8, 2012 |
| Countries | Romania, Spain |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: